A blog by Bob Fiddaman, award winning writer from Birmingham. Covering the dangers of antidepressant medication, the pharmaceutical industry and medicine regulators.
I must say, given all the distinguished and "powerful" people who visit your site, it truly is an honour to be the first to sign your Guestbook!
Ahem... I thoroughly enjoy the coverage of current GSK (and related) events, along with the "in your face" nature of the coverage. I think it would be good if guests from within the industry could maybe be invited to write a piece for you, from time-to-time. Perhaps Professor Sir Alasdair (that's "D-A-I-R") Breckenridge could be the first, just for added piquancy? I'm sure he'd be delighted to join the debate, given his stated desire to "nail" this topic.
Anyway, that's just something to think about. Keep up the good work!
I must say, given all the distinguished and "powerful" people who visit your site, it truly is an honour to be the first to sign your Guestbook!
ReplyDeleteAhem... I thoroughly enjoy the coverage of current GSK (and related) events, along with the "in your face" nature of the coverage. I think it would be good if guests from within the industry could maybe be invited to write a piece for you, from time-to-time. Perhaps Professor Sir Alasdair (that's "D-A-I-R") Breckenridge could be the first, just for added piquancy? I'm sure he'd be delighted to join the debate, given his stated desire to "nail" this topic.
Anyway, that's just something to think about. Keep up the good work!
Matt